NCT07218692 2025-10-20
RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy
City of Hope Medical Center
Phase 2 Not yet recruiting
City of Hope Medical Center
University of California, San Francisco
European Organisation for Research and Treatment of Cancer - EORTC
Mabpro, a.s.